#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Journal of Czech Physicians / 2026 - 2

Obesity during pregnancy –⁠ health risks and prevention options

Czech version

Authors: Kateřina Anderlová 1,2;  Antonín Pařízek 1;  Jitka Jírová 3,4
Authors‘ workplace: Klinika gynekologie, porodnictví a neonatologie 1. LF UK a VFN v Praze 1;  3. interní klinika – klinika endokrinologie a metabolismu 1. LF UK a VFN v Praze 2;  Ústav zdravotnických informací a statistiky ČR, Praha 3;  Katedra demografie a geodemografie, Přírodovědecká fakulta UK v Praze 4
Published in: Čas. Lék. čes. 2026; 165: 61-64
Category: Review Article

Overview

Obesity during pregnancy is a significant health problem with increasing prevalence in the population of women of reproductive age. It is associated with an increased risk of maternal and fetal complications, adverse perinatal outcomes, and long-term health effects on both mother and child. The aim of this article is to summarize current knowledge about the impact of obesity on pregnancy, childbirth, and the postpartum period, and to outline options for prevention and management.

Keywords:

prevention – perinatal outcomes – obesity in pregnancy – maternal and fetal complications – obesity prevalence

Sources
  1. Sagi-Dain L. Obesity in pregnancy: ACOG practice bulletin, number 230. Obstet Gynecol 2021; 138 : 489.
  2. Grieger JA, Hutchesson MJ, Cooray SD et al. A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum. Ther Adv Reprod Health 2021; 15 : 2633494120986544.
  3. Agrawal R, Lathia T. Obesity during pregnancy: contemporary evidence and clinical implications. Curr Opin Endocrinol Diabetes Obes 2025; 32 : 286-295.
  4. Yen IW, Lee CN, Lin MW et al. Overweight and obesity are associated with clustering of metabolic risk factors in early pregnancy and the risk of GDM. PLoS One 2019; 14: e0225978.
  5. Rassie K, Giri R, Joham AE et al. Human placental lactogen in relation to maternal metabolic health and fetal outcomes: a systematic review and meta-analysis. Int J Mol Sci 2022; 23 : 15621.
  6. Marchi J, Berg M, Dencker A et al. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev 2015; 16 : 621–638.
  7. Mukhtar F. A systematic review of the management of maternal obesity in pregnancy: antenatal management, outcomes, and long-term implications on maternal health. Cureus 2025; 17: e87258.
  8. Weir TL, Majumder M, Glastras SJ. A systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes. Obes Rev 2024; 25: e13747.
  9. Kelly AC, Powell TL, Jansson T. Placental function in maternal obesity. Clin Sci (Lond) 2020; 134 : 961–984.
  10. Ramanlal I, James JL, Boss AL. The impact of obesity on placental vascular development and function. Mol Hum Reprod 2026; 32: gaag002.
  11. Brombach C, Tong W, Giussani DA. Maternal obesity: new placental paradigms unfolded. Trends Mol Med 2022; 28 : 823–835.
  12. Griffiths A, Shannon OM, Brown T et al. Associations between anxiety, depression, and weight status during and after pregnancy: a systematic review and meta-analysis. Obes Rev 2024; 25: e13668.
  13. Athar U, Ain Daud NUA, Khan WA et al. Caught between external pressures and internal battles: psychosocial factors affecting gestational weight gain –⁠ a scoping review. Cureus 2021; 13 : 13487.
  14. Goldstein RF, Khomami BM, Tay CT et al. Gestational weight gain and risk of adverse maternal and neonatal outcomes in observational data from 1.6 million women: systematic review and meta-analysis. Brit Med J 2025; 391: bmj-2025-085710.
  15. Deshpande S, Ross S, Rajesh S et al. Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years-summary of new NICE guidance. Brit Med J 2025; 389: r954.
  16. Shen CMM, Fu WMB Fang, Chunxia MM et al. The impact of weight loss for obese infertile women prior to in vitro fertilization: a retrospective cohort study. Medicine 2023; 102: e33009.
  17. Legro S, Hansen KR, Diamond MP et al. Effects of preconception lifestyle intervention in infertile women with obesity: the FIT-PLESE randomized controlled trial. PLoS Med 2022; 19: e1003883.
  18. Cha E, Smart MJ, Braxter BJ et al. Preconception care to reduce the risks of overweight and obesity in women of reproductive age: an integrative review. Int J Environ Res Public Health 2021; 18 : 4582.
  19. Caldwell AE, Gorczyca AM, Bradford AP et al. Effectiveness of preconception weight loss interventions on fertility in women: a systematic review and meta-analysis. Fertil Steril 2024; 122 : 326–340.
  20. Johansson K, Bodnar LM, Stephansson O et al. Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study. Lancet. 2024; 403(10435): 1472–1481.
  21. Parker CH, Slattery C, Brennan et al. Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: safety data from regulatory clinical trials. Diabetes Obes Metab 2025; 27 : 4102–4108.
  22. Nuako A, Tu L, Reyes KJC et al. Pharmacologic treatment of obesity in reproductive aged Women. Curr Obstet Gynecol Rep 2023; 12 : 138–146.
  23. Dao K, Shechtman S, Weber-Schoendorfer C et al. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. Brit Med J Open 2024; 14: e083550.
  24. Shawe J, Ceulemans D, Akhter Z et al. Pregnancy after bariatric surgery: Consensus recommendations for periconception, antenatal and postnatal care. Obes Rev 2019; 20 : 1507–1522.
  25. American Diabetes Association Professional Practice Committee. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2025. Diabetes Care 2025; 48(Suppl 1): S167–S180.

Adresa pro korespondenci:

MUDr. Kateřina Anderlová, Ph.D.

Klinika gynekologie, porodnictví a neonatologie 1. LF UK a VFN

Apolinářská 441/18, 128 08 Praha 2

e-mail: katerina.anderlova@vfn.cz

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Telemedicine video consultations in the Czech Republic and their practical implementation in outpatient practice
Colorectal cancer and comorbidities – implications for surgical practice
Periodontitida a diabetes mellitus 2. typu
European Partnership for Personalised Medicine (EP PerMed)
Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece)
Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago
MUDr. Václav Náprstek – zapomenutý hrdina
The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950–1990
Pokyny pro autory a autorky Časopisu lékařů českých – výtah
Article was published in

Journal of Czech Physicians

Issue 2
2026 Issue 2
Download issue PDF
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#